Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
GEMAMEDIC from Sint-Pieters-Woluwe, company number BE0885952567, closed financial year 2025 with a result of € 50,669 after tax. For that financial year GEMAMEDIC recorded a gross margin of € 344,787 and equity of € 129,889. Compared with financial year 2024, the result moved from € -4,708 to € 50,669. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.
€ 129,889
▲ 64% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 50,669
▲ still € 4,708 loss in 2024
Profit after tax over the fiscal year.
€ 151,519
▲ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 111,289.
People and assets in 2025
5.5
▼ 0.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 243,344
▼ 6% vs 2024
€ 44,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 26,987
▼ 24% vs 2024
Of which on lease € 19,940.
Debts at end 2025
€ 25,773
▼ 14% vs 2024
€ 4,802 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 60,550
▲ 43% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 43,885
▲ 17% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 245,453 | € 341,086 | € 279,772 | € 344,787 | ▲ 23% |
| Profit after taxes | € 9,814 | € 63,159 | € -4,708 | € 50,669 | ▲ € 55,377 |
| Equity | € 20,768 | € 83,927 | € 79,219 | € 129,889 | ▲ 64% |
| Total debts | € 432,006 | € 579,542 | € 611,836 | € 628,397 | ▲ 3% |
| Cash | € 85,133 | € 151,810 | € 116,769 | € 151,519 | ▲ 30% |
| Retained profit | € 2,168 | € 65,327 | € 60,619 | € 111,289 | ▲ 84% |
| Bank debt | € 283 | € 34,233 | € 30,111 | € 25,773 | ▼ 14% |
| Balance sheet total | € 452,774 | € 663,469 | € 691,055 | € 758,286 | ▲ 10% |
| Employees (FTE) | 5.1 | 4.5 | 6.1 | 5.5 | ▼ 0.6 |
Key figures of GEMAMEDIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GEMAMEDIC?
What happened at GEMAMEDIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 50,669. filed late Source: NBB ↗
- CAREVIEW SRL became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Sint-Pieters-Woluwe. KBO
In short
From € 9,814 profit in 2022 to € 50,669 profit in 2025.
Paid € 60,742 in corporate taxes since 2022.
Best year ever: 2023, with € 63,159 profit.
On average € 62,700 of value added per employee in 2025.
A new publication or filing at GEMAMEDIC? We notify you, reason included.
Follow GEMAMEDICDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of CareView, PSYCARD comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
GEMAMEDICBehind GEMAMEDIC is CAREVIEW SRL. The shares are held by CareView (100%) and PSYCARD (8%).
Directors
According to the 2025 annual accounts
since 2019
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Gebroeders Legrainlaan 85
1150 Sint-Pieters-Woluwe
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0885.952.567
- VAT number
- BE 0885.952.567
- Registered office
- Gebroeders Legrainlaan 85, 1150 Sint-Pieters-Woluwe
- Names & denominations
- GEMAMEDIC
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 December 2006
- Peppol
- Not registered
- Activities · NACE
Activiteiten van huisartspraktijken
Medische praktijken